In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate

Patricia A. Lang net worth and biography

Patricia Lang Biography and Net Worth

SVP of Enovis

With more than 25 years in human resources and related fields, Patricia Lang brings significant expertise, as well as great in-depth knowledge and experience in the diligence, acquisition, and successful integration of complex multicultural companies. Most recently, she was the Chief People Officer for Diebold Nixdorf and was responsible for managing associate-focused initiatives across the organization for more than 24,000 associates. Prior to joining Diebold Nixdorf, she held a number of human resources and operations leadership positions at companies such as Mylan Pharmaceuticals, CONSOL Energy, Mercer Consulting, and Cigna. Ms. Lang holds a business degree with a concentration in Information Technology and Management from Duquesne University. Additionally, she holds various certifications in human capital management, mergers and acquisitions, global associate benefits (including CEBS), as well as complex project management, lean manufacturing business systems, and the Toyota Production System. Ms. Lang has served on the American Bath Group Board of Directors since February 2021 and is a member of their Compensation Committee.

What is Patricia A. Lang's net worth?: The estimated net worth of Patricia A. Lang is at least $911,506.14 as of March 6th, 2023. Ms. Lang owns 19,653 shares of Enovis stock worth more than $911,506 as of November 17th. This net worth evaluation does not reflect any other investments that Ms. Lang may own. Additionally, Ms. Lang receives a salary of $1,010,000.00 as SVP at Enovis. Learn More about Patricia A. Lang's net worth.
How old is Patricia A. Lang?: Ms. Lang is currently 65 years old. There are 6 older executives and no younger executives at Enovis. Learn More on Patricia A. Lang's age.
What is Patricia A. Lang's salary?: As the SVP of Enovis Co., Ms. Lang earns $1,010,000.00 per year. There are 4 executives that earn more than Ms. Lang. The highest earning executive at Enovis is Mr. Matthew L. Trerotola, CEO & Chairman, who commands a salary of $3,350,000.00 per year. Learn More on Patricia A. Lang's salary.
How do I contact Patricia A. Lang?: The corporate mailing address for Ms. Lang and other Enovis executives is 2711 Centerville Road Suite 400, Wilmington DE, 19808. Enovis can also be reached via phone at 302-252-9160 and via email at [email protected]. Learn More on Patricia A. Lang's contact information.
Has Patricia A. Lang been buying or selling shares of Enovis?: Patricia A. Lang has not been actively trading shares of Enovis within the last three months. Most recently, Patricia A. Lang sold 745 shares of the business's stock in a transaction on Monday, March 6th. The shares were sold at an average price of $57.69, for a transaction totalling $42,979.05. Following the completion of the sale, the senior vice president now directly owns 19,653 shares of the company's stock, valued at $1,133,781.57. Learn More on Patricia A. Lang's trading history.
Who are Enovis' active insiders?: Enovis' insider roster includes Benjamin Berry (CFO), Christopher Hix (CFO), John Kleckner (Insider), Patricia Lang (SVP), A. Perfall (Director), Daniel Pryor (EVP), Brady Shirley (COO), Bradley Tandy (SVP), Matthew Trerotola (CEO), and Rajiv Vinnakota (Director). Learn More on Enovis' active insiders.

Patricia A. Lang Insider Trading History at Enovis

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/6/2023	Sell	745	$57.69	$42,979.05	19,653
2/23/2023	Sell	440	$54.61	$24,028.40	14,416
2/21/2023	Sell	545	$62.11	$33,849.95	14,856

Patricia A. Lang Buying and Selling Activity at Enovis

Enovis Company Overview

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Today's Range

Now: $46.38

$45.31

$46.61

50 Day Range

MA: $42.44

$38.72

$47.86

2 Week Range

Now: $46.38

$38.27

$65.03

Volume

467,649 shs

Average Volume

765,955 shs

Market Capitalization

$2.59 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.91

Bill Gates’s Next Big AI Bet: Stargate

From Brownstone Research | Ad